Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A uniquely positioned Canadian market Novo Nordisk's data exclusivity for semaglutide expired in Canada on January 4, 2026, following a lapse in key Canadian patent protection tied to a maintenance-fee issue
Long-term safety studies to address variability in plant extracts.
It is especially important for energy and fat metabolism
Ongoing clinical support : Unlimited access to 1:1 telehealth visits and chat messaging with specially trained weight loss clinicians
Patients should contact their GP or prescribing clinician if they experience: Severe or persistent abdominal pain , particularly in the upper right quadrant or radiating to the back, which could indicate biliary complications such as bile duct stones or pancreatitis Persistent vomiting that prevents adequate fluid or medication intake, risking dehydration Signs of dehydration including dark urine, dizziness, reduced urination, or extreme thirst Jaundice (yellowing of skin or eyes), which may suggest bile duct obstruction Severe diarrhoea lasting more than 48 hours or accompanied by blood Unexplained fever with abdominal symptoms Pancreatitis is a rare but serious potential side effect of GLP-1 receptor agonists
while this risk is less relevant for injectable forms, caution is still advised in patients with reactive airway diseases
